|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
5 terms
|
 |
|
Biochemical function
|
enzyme binding
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
90:5167-5171
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.
|
|
C.P.Hill,
T.D.Osslund,
D.Eisenberg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have determined the three-dimensional structure of recombinant human
granulocyte-colony-stimulating factor by x-ray crystallography. Phases were
initially obtained at 3.0-A resolution by multiple isomorphous replacement and
were refined by solvent flattening and by averaging of the electron density of
the three molecules in the asymmetric unit. The current R factor is 21.5% for
all data between 6.0- and 2.2-A resolution. The structure is predominantly
helical, with 104 of the 175 residues forming a four-alpha-helix bundle. The
only other secondary structure is also helical. In the loop between the first
two long helices a four-residue 3(10)-helix is immediately followed by a
6-residue alpha-helix. Three residues in the short connection between the second
and third bundle helices form almost one turn of left-handed helix. The
up-up-down-down connectivity with two long crossover connections has been
reported previously for five other proteins, which like
granulocyte-colony-stimulating factor are all signaling ligands: growth hormone,
granulocyte/macrophage-colony-stimulating factor, interferon beta, interleukin
2, and interleukin 4. Structural similarity among these growth factors occurs
despite the absence of similarity in their amino acid sequences. Conservation of
this tertiary structure suggests that these different growth factors might all
bind to their respective sequence-related receptors in an equivalent manner.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.T.Vaiphei,
L.Mao,
T.Shimazu,
J.H.Park,
and
M.Inouye
(2010).
Use of amino acids as inducers for high-level protein expression in the single-protein production system.
|
| |
Appl Environ Microbiol, 76,
6063-6068.
|
 |
|
|
|
|
 |
D.M.Piedmonte,
and
M.J.Treuheit
(2008).
Formulation of Neulasta (pegfilgrastim).
|
| |
Adv Drug Deliv Rev, 60,
50-58.
|
 |
|
|
|
|
 |
R.Khalilzadeh,
J.Mohammadian-Mosaabadi,
A.Bahrami,
A.Nazak-Tabbar,
M.A.Nasiri-Khalili,
and
A.Amouheidari
(2008).
Process development for production of human granulocyte-colony stimulating factor by high cell density cultivation of recombinant Escherichia coli.
|
| |
J Ind Microbiol Biotechnol, 35,
1643-1650.
|
 |
|
|
|
|
 |
L.R.Zhao,
Y.Navalitloha,
S.Singhal,
J.Mehta,
C.S.Piao,
W.P.Guo,
J.A.Kessler,
and
D.R.Groothuis
(2007).
Hematopoietic growth factors pass through the blood-brain barrier in intact rats.
|
| |
Exp Neurol, 204,
569-573.
|
 |
|
|
|
|
 |
R.S.Rajan,
T.Li,
M.Aras,
C.Sloey,
W.Sutherland,
H.Arai,
R.Briddell,
O.Kinstler,
A.M.Lueras,
Y.Zhang,
H.Yeghnazar,
M.Treuheit,
and
D.N.Brems
(2006).
Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study.
|
| |
Protein Sci, 15,
1063-1075.
|
 |
|
|
|
|
 |
R.Thirumangalathu,
S.Krishnan,
D.N.Brems,
T.W.Randolph,
and
J.F.Carpenter
(2006).
Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor.
|
| |
J Pharm Sci, 95,
1480-1497.
|
 |
|
|
|
|
 |
G.D.Pipes,
A.A.Kosky,
J.Abel,
Y.Zhang,
M.J.Treuheit,
and
G.R.Kleemann
(2005).
Optimization and applications of CDAP labeling for the assignment of cysteines.
|
| |
Pharm Res, 22,
1059-1068.
|
 |
|
|
|
|
 |
S.W.Raso,
J.Abel,
J.M.Barnes,
K.M.Maloney,
G.Pipes,
M.J.Treuheit,
J.King,
and
D.N.Brems
(2005).
Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.
|
| |
Protein Sci, 14,
2246-2257.
|
 |
|
|
|
|
 |
E.Y.Chi,
S.Krishnan,
B.S.Kendrick,
B.S.Chang,
J.F.Carpenter,
and
T.W.Randolph
(2003).
Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.
|
| |
Protein Sci, 12,
903-913.
|
 |
|
|
|
|
 |
M.S.Ricci,
C.A.Sarkar,
E.M.Fallon,
D.A.Lauffenburger,
and
D.N.Brems
(2003).
pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor.
|
| |
Protein Sci, 12,
1030-1038.
|
 |
|
|
|
|
 |
S.K.Nair,
and
S.K.Burley
(2003).
X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
|
| |
Cell, 112,
193-205.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.N.Brems
(2002).
The kinetics of G-CSF folding.
|
| |
Protein Sci, 11,
2504-2511.
|
 |
|
|
|
|
 |
K.Morikawa
(2002).
[Ligand recognition mechanism of G-CSF receptor and metabotropic glutamate receptor]
|
| |
Yakugaku Zasshi, 122,
855-868.
|
 |
|
|
|
|
 |
L.Hareng,
and
T.Hartung
(2002).
Induction and regulation of endogenous granulocyte colony-stimulating factor formation.
|
| |
Biol Chem, 383,
1501-1517.
|
 |
|
|
|
|
 |
P.Luo,
R.J.Hayes,
C.Chan,
D.M.Stark,
M.Y.Hwang,
J.M.Jacinto,
P.Juvvadi,
H.S.Chung,
A.Kundu,
M.L.Ary,
and
B.I.Dahiyat
(2002).
Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening.
|
| |
Protein Sci, 11,
1218-1226.
|
 |
|
|
|
|
 |
M.L.Fernández,
G.D.Cymes,
L.M.Curto,
and
C.Wolfenstein-Todel
(2000).
Ovine placental lactogen and ovine prolactin: partial proteolysis and conformational stability.
|
| |
Int J Biochem Cell Biol, 32,
597-608.
|
 |
|
|
|
|
 |
C.A.McWherter,
Y.Feng,
L.L.Zurfluh,
B.K.Klein,
M.P.Baganoff,
J.O.Polazzi,
W.F.Hood,
K.Paik,
A.L.Abegg,
E.S.Grabbe,
J.J.Shieh,
A.M.Donnelly,
and
J.P.McKearn
(1999).
Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
|
| |
Biochemistry, 38,
4564-4571.
|
 |
|
|
|
|
 |
J.Grötzinger,
T.Kernebeck,
K.J.Kallen,
and
S.Rose-John
(1999).
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
|
| |
Biol Chem, 380,
803-813.
|
 |
|
|
|
|
 |
Y.Feng,
J.C.Minnerly,
L.L.Zurfluh,
W.D.Joy,
W.F.Hood,
A.L.Abegg,
E.S.Grabbe,
J.J.Shieh,
T.L.Thurman,
J.P.McKearn,
and
C.A.McWherter
(1999).
Circular permutation of granulocyte colony-stimulating factor.
|
| |
Biochemistry, 38,
4553-4563.
|
 |
|
|
|
|
 |
J.L.Taupin,
V.Pitard,
J.Dechanet,
V.Miossec,
N.Gualde,
and
J.F.Moreau
(1998).
Leukemia inhibitory factor: part of a large ingathering family.
|
| |
Int Rev Immunol, 16,
397-426.
|
 |
|
|
|
|
 |
J.M.Matthews,
A.Hammacher,
G.J.Howlett,
and
R.J.Simpson
(1998).
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
|
| |
Biochemistry, 37,
10671-10680.
|
 |
|
|
|
|
 |
M.Höglund
(1998).
Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
|
| |
Med Oncol, 15,
229-233.
|
 |
|
|
|
|
 |
M.Yamasaki,
N.Konishi,
K.Yamaguchi,
S.Itoh,
and
Y.Yokoo
(1998).
Purification and characterization of recombinant human granulocyte colony-stimulating factor (rhG-CSF) derivatives: KW-2228 and other derivatives.
|
| |
Biosci Biotechnol Biochem, 62,
1528-1534.
|
 |
|
|
|
|
 |
R.J.Duhé,
G.A.Evans,
R.A.Erwin,
R.A.Kirken,
G.W.Cox,
and
W.L.Farrar
(1998).
Nitric oxide and thiol redox regulation of Janus kinase activity.
|
| |
Proc Natl Acad Sci U S A, 95,
126-131.
|
 |
|
|
|
|
 |
S.A.Benner,
N.Trabesinger,
D.Schreiber,
and
S.A.Benner
(1998).
Post-genomic science: converting primary structure into physiological function.
|
| |
Adv Enzyme Regul, 38,
155-180.
|
 |
|
|
|
|
 |
D.C.Young,
H.Zhan,
Q.L.Cheng,
J.Hou,
and
D.J.Matthews
(1997).
Characterization of the receptor binding determinants of granulocyte colony stimulating factor.
|
| |
Protein Sci, 6,
1228-1236.
|
 |
|
|
|
|
 |
D.H.Purvis,
and
B.C.Mabbutt
(1997).
Solution dynamics and secondary structure of murine leukemia inhibitory factor: a four-helix cytokine with a rigid CD loop.
|
| |
Biochemistry, 36,
10146-10154.
|
 |
|
|
|
|
 |
J.G.Zhang,
J.M.Matthews,
L.D.Ward,
and
R.J.Simpson
(1997).
Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state.
|
| |
Biochemistry, 36,
2380-2389.
|
 |
|
|
|
|
 |
J.M.Matthews,
L.D.Ward,
A.Hammacher,
R.S.Norton,
and
R.J.Simpson
(1997).
Roles of histidine 31 and tryptophan 34 in the structure, self-association, and folding of murine interleukin-6.
|
| |
Biochemistry, 36,
6187-6196.
|
 |
|
|
|
|
 |
K.Yamasaki,
S.Naito,
H.Anaguchi,
T.Ohkubo,
and
Y.Ota
(1997).
Solution structure of an extracellular domain containing the WSxWS motif of the granulocyte colony-stimulating factor receptor and its interaction with ligand.
|
| |
Nat Struct Biol, 4,
498-504.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.J.Simpson,
A.Hammacher,
D.K.Smith,
J.M.Matthews,
and
L.D.Ward
(1997).
Interleukin-6: structure-function relationships.
|
| |
Protein Sci, 6,
929-955.
|
 |
|
|
|
|
 |
T.Li,
T.Horan,
T.Osslund,
G.Stearns,
and
T.Arakawa
(1997).
Conformational changes in G-CSF/Receptor complex as investigated by isotope-edited FTIR spectroscopy.
|
| |
Biochemistry, 36,
8849-8857.
|
 |
|
|
|
|
 |
V.Gervais,
A.Zerial,
and
H.Oschkinat
(1997).
NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony-stimulating factor.
|
| |
Eur J Biochem, 247,
386-395.
|
 |
|
|
|
|
 |
W.Somers,
M.Stahl,
and
J.S.Seehra
(1997).
1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.
|
| |
EMBO J, 16,
989-997.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.M.Rourke,
Y.Cha,
and
D.Collins
(1996).
Stabilization of granulocyte colony-stimulating factor and structurally analogous growth factors by anionic phospholipids.
|
| |
Biochemistry, 35,
11913-11917.
|
 |
|
|
|
|
 |
A.S.Goldman,
S.Chheda,
R.Garofalo,
and
F.C.Schmalstieg
(1996).
Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate.
|
| |
J Mammary Gland Biol Neoplasia, 1,
251-258.
|
 |
|
|
|
|
 |
C.Nishimura,
A.Watanabe,
H.Gouda,
I.Shimada,
and
Y.Arata
(1996).
Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.
|
| |
Biochemistry, 35,
273-281.
|
 |
|
|
|
|
 |
G.D.Cymes,
C.Grosman,
J.M.Delfino,
and
C.Wolfenstein-Todel
(1996).
Detection and characterization of an ovine placental lactogen stable intermediate in the urea-induced unfolding process.
|
| |
Protein Sci, 5,
2074-2079.
|
 |
|
|
|
|
 |
J.F.Reidhaar-Olson,
J.A.De Souza-Hart,
and
H.E.Selick
(1996).
Identification of residues critical to the activity of human granulocyte colony-stimulating factor.
|
| |
Biochemistry, 35,
9034-9041.
|
 |
|
|
|
|
 |
R.C.Hoffman,
H.Andersen,
K.Walker,
J.D.Krakover,
S.Patel,
M.R.Stamm,
and
S.G.Osborn
(1996).
Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246.
|
| |
Biochemistry, 35,
14849-14861.
|
 |
|
|
|
|
 |
S.Kumar,
and
M.Bansal
(1996).
Structural and sequence characteristics of long alpha helices in globular proteins.
|
| |
Biophys J, 71,
1574-1586.
|
 |
|
|
|
|
 |
A.Gustchina,
A.Zdanov,
C.Schalk-Hihi,
and
A.Wlodawer
(1995).
A model of the complex between interleukin-4 and its receptors.
|
| |
Proteins, 21,
140-148.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Diederichs
(1995).
Structural superposition of proteins with unknown alignment and detection of topological similarity using a six-dimensional search algorithm.
|
| |
Proteins, 23,
187-195.
|
 |
|
|
|
|
 |
M.H.Seto,
R.N.Harkins,
M.Adler,
M.Whitlow,
W.B.Church,
and
E.Croze
(1995).
Homology model of human interferon-alpha 8 and its receptor complex.
|
| |
Protein Sci, 4,
655-670.
|
 |
|
|
|
|
 |
N.Q.McDonald,
N.Panayotatos,
and
W.A.Hendrickson
(1995).
Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing.
|
| |
EMBO J, 14,
2689-2699.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Hammacher,
L.D.Ward,
J.Weinstock,
H.Treutlein,
K.Yasukawa,
and
R.J.Simpson
(1994).
Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
|
| |
Protein Sci, 3,
2280-2293.
|
 |
|
|
|
|
 |
C.J.Morton,
R.J.Simpson,
and
R.S.Norton
(1994).
Solution structure of synthetic peptides corresponding to the C-terminal helix of interleukin-6.
|
| |
Eur J Biochem, 219,
97.
|
 |
|
|
|
|
 |
D.A.Rozwarski,
A.M.Gronenborn,
G.M.Clore,
J.F.Bazan,
A.Bohm,
A.Wlodawer,
M.Hatada,
and
P.A.Karplus
(1994).
Structural comparisons among the short-chain helical cytokines.
|
| |
Structure, 2,
159-173.
|
 |
|
|
|
|
 |
R.J.Kreitman,
R.K.Puri,
and
I.Pastan
(1994).
A circularly permuted recombinant interleukin 4 toxin with increased activity.
|
| |
Proc Natl Acad Sci U S A, 91,
6889-6893.
|
 |
|
|
|
|
 |
R.Savino,
A.Lahm,
A.L.Salvati,
L.Ciapponi,
E.Sporeno,
S.Altamura,
G.Paonessa,
C.Toniatti,
and
G.Ciliberto
(1994).
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.
|
| |
EMBO J, 13,
1357-1367.
|
 |
|
|
|
|
 |
A.Wlodawer,
A.Pavlovsky,
and
A.Gustchina
(1993).
Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding.
|
| |
Protein Sci, 2,
1373-1382.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|